Please login to the form below

empagliflozin

This page shows the latest empagliflozin news and features for those working in and with pharma, biotech and healthcare.

The EMPEROR-Reduced trial evaluated SGLT2 inhibitor Jardiance (empagliflozin) in patients with heart failure with reduced ejection fraction (HFrEF).

Merck, Bayer flesh out vericiguat heart failure data at ACC

Some outstanding questions include where vericiguat lies in relation to the SGLT2 inhibitors such as Boehringer Ingelheim/Eli Lilly’s Jardiance (empagliflozin) and AstraZeneca’s Farxiga/Forxiga (dapagliflozin), which are also
FDA says no to Lilly, Boehringer’s Jardiance in type 1 diabetes

Jardiance (empagliflozin) is already approved to treat type 2 diabetes, but Lilly and Boehringer had been hoping to expand the number if patients eligible for treatment with the drug by making
Trial of Amgen, Servier’s heart failure drug clears interim check

Other drugs in the SGLT2 class – including Boehringer Ingelheim and Eli Lilly’s Jardiance (empagliflozin) – are also being tested in heart failure indications.
Givlaari, Rybelsus lead crowded CHMP recommendations

Lilly’s SGLT2 inibitor Jardiance (empagliflozin) and Victoza, as well as placebo.
AstraZeneca’s heart failure drug Farxiga scores FDA priority review

AZ is hoping to make some gains on SGLT2 inhibitor market leader Jardiance (empagliflozin) from Eli Lilly and Boehringer Ingelheim.

More from news
Approximately 16 fully matching, plus 83 partially matching documents found.

Market dynamics, marketing and analytics

The remaining two SGLT2s are growing faster than the market, with Jardiance (empagliflozin) leading the market in terms of growth.
Interview: Christopher Boulton, AstraZeneca

s empagliflozin, but AstraZeneca's strength is the wide range of oral diabetes products it has to offer, says Boulton.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Add my company

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping: Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much: Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website: You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...